Showing results (1-10 of 86) with videos related to
Sort By:
Pageof 9
Expert Review of Gastroenterology & Hepatology|March 25, 2014
Mucosal healing as a treatment for IBD?Claudio Papi, Annalisa AratariDigestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 9, 2016
Short term colectomy rate and mortality for severe ulcerative colitis in the last 40 years. Has something changed?Valeria Clemente, Annalisa Aratari, Claudio Papi, et al.Journal of Clinical Medicine|June 13, 2025
Changes in Medical Management of Inflammatory Bowel Disease and Reducing Surgical Risk: Investigating Causality Through the Bradford-Hill CriteriaDaniela Maggi, Claudio Papi, Stefano Festa, et al.Reviews on Recent Clinical Trials|October 25, 2012
Randomized controlled trials in prevention of postsurgical recurrence in Crohn's diseaseClaudio Papi, Federica Fasci Spurio, Giovanna Margagnoni, et al.Recenti Progressi in Medicina|December 24, 2014
[Environmental factors and clinical course of inflammatory bowel disease: which evidences?]Annalisa Aratari, Giovanna Margagnoni, Ludovica Feigush, et al.Recenti Progressi in Medicina|December 16, 2015
[Evolving therapeutic targets in inflammatory Bowel Disease: mucosal healing as an emerging end point]Giovanna Condino, Giovanna Margagnoni, Annalisa Aratari, et al.Journal of Crohn'S & Colitis|December 3, 2010
Methotrexate-induced pneumonitis in a patient with Crohn's diseaseGiovanna Margagnoni, Valeria Papi, Annalisa Aratari, et al.Recenti Progressi in Medicina|February 17, 2018
[Towards new therapeutic paradigms beyond symptom control in the management of inflammatory bowel diseases.]Stefano Festa, Giulia Zerboni, Annalisa Aratari, et al.Journal of Gastrointestinal and Liver Diseases : JGLD|March 30, 2012
Early treatment in Crohn's disease: do we have enough evidence to reverse the therapeutic pyramid?Federica Fascì Spurio, Annalisa Aratari, Giovanna Margagnoni, et al.Recenti Progressi in Medicina|May 30, 2019
[The advantages of patient's active involvement in the management of chronic Inflammatory Bowel Diseases.]Giulia Zerboni, Stefano Festa, Annalisa Aratari, et al.Pageof 9